Latest Insights

Shaping the Future of Medicine: Top Healthcare and Pharmaceutical Trends

October 28, 2024

Innovations in technology, evolving patient expectations, and global challenges are driving rapid transformations in the healthcare and pharmaceutical sectors, leading private equity firms to focus on investing in businesses that will shape the future of medicine.

In 2024, several key trends are influencing the industry, from technological advancements to new regulations and evolving market dynamics.


Here are some of the key trends you need to know:

Telemedicine, Telehealth and Remote Healthcare

One of the most significant trends in healthcare today is the rise of telemedicine. 


Telemedicine and telehealth include various technologies, such as video calls, mobile apps, remote monitoring devices, and electronic health records, to provide healthcare services remotely. These tools allow patients to consult with doctors from home, reducing geographical barriers and improving accessibility, especially for those with mobility issues, in rural areas, or requiring specialised care. 


The COVID-19 pandemic has accelerated the adoption of such digital health solutions, with teleconsultations, remote patient monitoring, and mobile health apps becoming integral to healthcare delivery. 


The global telehealth market is projected to grow at a 26.6% compound annual growth rate (CAGR), reaching $285.7 billion by 2027, up from $87.8 billion in 2022. Virtual care, including mental health services, is becoming an integral part of healthcare systems and in the past few years, we have seen substantial investments in telemedicine platforms and digital health startups. One such notable event includes the $17 billion buyout of healthtech company Athenahealth by Hellman & Friedman and Bain Capital.



Genomics and Precision Medicine

Precision medicine, tailors’ treatments to the unique characteristics of each patient and breakthroughs in genomics and biotechnology are enabling therapies to be customised based on these unique characteristics in an individual's genetic profile. This approach is especially promising in oncology, where targeted treatments can greatly enhance patient outcomes. 


The global personalised medicine market was valued at USD 529.28 billion in 2023 and is expected to grow at a CAGR of 8.20% from 2024 to 2030. Major advancements such as the conclusion of the Human Genome Project and the CRISPR gene-editing technology are fueling this movement, facilitating more accurate therapies for illnesses like cancer, rare genetic disorders, and cardiovascular diseases.



Artificial Intelligence (AI) in Drug Discovery

The pharmaceutical industry is increasingly using AI to speed up drug discovery and development. AI algorithms can analyse vast datasets, identify potential drug candidates, and predict how compounds will interact with biological systems. This can help to shorten development timelines and reduce costs by up to 70% according to an Insider Intelligence report, further enhancing the precision and efficiency of healthcare.


Pfizer, Novartis, and Merck are among the major players in the industry that have already begun using AI to optimise their R&D processes. As such, the continued interest of firms in the role of AI within the healthcare industry is not surprising.


With the ongoing integration of AI into pharmaceutical companies, there will be a heightened demand for skilled professionals to handle and innovate within these advanced systems, leading to a significant increase in hiring across the healthcare and tech sectors.


If you are interested in exploring salary ranges within the healthcare industry, check out  FP Global’s 2024 Healthcare Salary Guide for detailed insights into current compensation trends!

The healthcare and pharmaceutical industries are experiencing major changes in 2024, with telemedicine, AI-powered drug discovery, and personalised medicine transforming healthcare delivery. At the same time, the growth of biopharmaceuticals and regenerative medicine is improving patient outcomes and driving a shift towards a more efficient, patient-centred healthcare system. As these trends evolve, healthcare providers, pharmaceutical companies, and policymakers will need to adapt to meet the increasing demands and expectations of patients globally. 


Leverage FP Global's expertise to boost the growth of your business when you partner with us for workforce management solutions by registering a vacancy, or reaching out to our specialist:

Share This Article

Articles You May Like

By Diana Teh January 27, 2025
As Chinese New Year approaches, many leaders in Hong Kong and Singapore’s hedge fund and asset management space are looking ahead to a fast-paced, transformative 2025.
By Diana Teh January 24, 2025
Leading a financial institution in Hong Kong or Singapore? You’ve likely felt the mounting pressure. Between digital banking, new regulatory frameworks, and ESG requirements, it’s easy to feel overwhelmed. If you’re asking, "Where do I find the specialised talent I need for tomorrow—while managing today's demands?" you're not alone.
By Diana Teh January 23, 2025
As the financial landscape continues to evolve in 2025, one thing is clear: hiring the right talent isn’t just about filling roles—it’s about aligning people with your organisation’s vision and long-term strategy.
By Diana Teh January 22, 2025
Beyond the headline challenges of economic growth and geopolitics, several overlooked issues could significantly impact Hong Kong and Singapore’s financial sectors this year.
By Lyn Thum January 21, 2025
I recently attended the 18th EY Singapore Alternative Fund Symposium on 15 January 2025. The symposium featured various panels, fireside chats, and presentations from industry leaders, covering a wide range of topics relevant to the alternative investment sector in 2025.
By Diana Teh January 27, 2025
As Chinese New Year approaches, many leaders in Hong Kong and Singapore’s hedge fund and asset management space are looking ahead to a fast-paced, transformative 2025.
By Diana Teh January 24, 2025
Leading a financial institution in Hong Kong or Singapore? You’ve likely felt the mounting pressure. Between digital banking, new regulatory frameworks, and ESG requirements, it’s easy to feel overwhelmed. If you’re asking, "Where do I find the specialised talent I need for tomorrow—while managing today's demands?" you're not alone.
By Diana Teh January 23, 2025
As the financial landscape continues to evolve in 2025, one thing is clear: hiring the right talent isn’t just about filling roles—it’s about aligning people with your organisation’s vision and long-term strategy.
By Diana Teh January 22, 2025
Beyond the headline challenges of economic growth and geopolitics, several overlooked issues could significantly impact Hong Kong and Singapore’s financial sectors this year.
By Lyn Thum January 21, 2025
I recently attended the 18th EY Singapore Alternative Fund Symposium on 15 January 2025. The symposium featured various panels, fireside chats, and presentations from industry leaders, covering a wide range of topics relevant to the alternative investment sector in 2025.
By Diana Teh January 20, 2025
Hong Kong remains a thriving hub for global financial markets, and as we move into 2025, its dynamism is undeniable. As a recruitment consultant, I’ve seen firsthand how the right talent strategies can shape success in this fast-paced industry. 
By Su Ling Lew November 22, 2024
The year 2024 has seen the Asian real estate market undergoing major changes, influenced by changing economic conditions, a rising focus on sustainability, and the market's shifting dynamics.
By Su Ling Lew November 14, 2024
Whether it’s a boutique firm or a large MNC, I’ve seen firsthand how essential culture fit is for long-term success.
By Hui Shuen Lim October 21, 2024
With RM1 billion set aside for local talent development and a whopping US$16.9 billion in investments attracted from global giants, Malaysia is positioning itself as a major player in the tech and digital space.
By Jacqueline Lee October 14, 2024
Private Equity (PE) firms have become significant players in the healthcare industry, a sector that is evolving rapidly due to technological advancements, regulatory changes, and shifting patient expectations.
More Posts
Share by: